×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.21 | -0.31 | NA | -1.25 | 0 | |
| TYCHE INDUSTRIES LTD. | 144.65 | 24.31 | 127.00 | 2.37 | 140.0 | 11.5 |
| CHOKSI LABORATORIES LTD. | 112.45 | 3.85 | 112.42 | 0.55 | 132 | 88.2 |
| BAL PHARMA LTD. | 663.76 | 3.23 | 656.35 | 0.2 | 132 | 18.4 |
Tyche Industries Ltd., with Security Code 532384, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.3 | 17.1 | 16.0 | 22.2 | 14.2 | 15.5 | 20.5 | 17.8 | 12.4 | 12.7 |
| Expenses | 20.1 | 14.3 | 12.9 | 17.4 | 12.3 | 12.9 | 15.8 | 12.9 | 12.5 | 10.8 |
| Operating Profit | 5.2 | 2.8 | 3.1 | 4.8 | 1.9 | 2.6 | 4.7 | 4.8 | -0.1 | 2.0 |
| OPM % | 20.4% | 16.41% | 19.56% | 21.74% | 13.24% | 16.84% | 22.96% | 27.23% | -1.07% | 15.35% |
| Other Income | 0.9 | 1.3 | 1.5 | 1.5 | 1.6 | 1.5 | 1.1 | 2.0 | 2.0 | 1.8 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Profit before tax | 5.6 | 3.6 | 4.2 | 5.9 | 2.9 | 3.6 | 6.1 | 6.4 | 1.4 | 3.3 |
| Tax % | -27% | -25.2% | -25.2% | -26.9% | -28.4% | -25.2% | -25.5% | -25.7% | -22.6% | -25.4% |
| Net Profit | 4.1 | 2.7 | 3.1 | 4.3 | 2.1 | 2.7 | 4.0 | 4.7 | 1.0 | 2.4 |
| EPS in Rs | 3.91 | 2.65 | 3.06 | 4.18 | 1.88 | 2.66 | 3.9 | 4.63 | 0 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 5% |
| 3 Years: | -4% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | -16% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| 1 Year: | -25% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|